Valuation: Terumo Corporation

Market Cap 3,380B 21.69B 18.9B 17.88B 16.25B 30.35B 2,078B 30.5B 213B 82.36B 1,056B 81.5B 79.68B P/E 2027 *
17.1x
P/E 2028 * 17.6x
Enterprise Value 3,426B 21.99B 19.15B 18.13B 16.47B 30.77B 2,106B 30.92B 216B 83.49B 1,070B 82.61B 80.77B EV / Sales 2027 *
2.72x
EV / Sales 2028 * 2.5x
Free-Float
97.07%
Yield 2027 *
1.62%
Yield 2028 * 1.77%
1 day+2.12%
1 week+1.04%
Current month-8.92%
1 month-14.26%
3 months+3.22%
6 months+10.46%
Current year+0.95%
1 week 2,194.5
Extreme 2194.5
2,313.5
1 month 2,194.5
Extreme 2194.5
2,650
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+2.12%+1.04%-9.09%+4.09% 21.34B
-0.13%-1.09%-23.81%+1.22% 177B
+0.18%+1.26%-1.91%+12.04% 118B
-2.85%-3.60%+7.03%+72.83% 60.78B
-0.26%+2.81%-3.30%-31.44% 49.53B
+1.18%-2.39%+4.57%+35.50% 48.29B
+0.68%+4.05%+15.03%-7.73% 32.96B
-2.64%-0.83% - - 28.94B
+1.27%+6.49%+42.85%-7.10% 25.48B
+1.13%+2.89%+11.87%-22.76% 21.77B
Average +0.07%+0.39%+4.80%+6.29% 58.47B
Weighted average by Cap. -0.14%-0.57%-4.15%+9.68%

Financials

2027 *2028 *
Net sales 1,259B 8.08B 7.04B 6.66B 6.05B 11.3B 774B 11.36B 79.33B 30.67B 393B 30.35B 29.68B 1,339B 8.6B 7.49B 7.09B 6.44B 12.03B 823B 12.09B 84.4B 32.63B 418B 32.29B 31.57B
Net income 195B 1.25B 1.09B 1.03B 938M 1.75B 120B 1.76B 12.3B 4.75B 60.96B 4.7B 4.6B 192B 1.23B 1.07B 1.02B 923M 1.73B 118B 1.73B 12.11B 4.68B 60.01B 4.63B 4.53B
Net Debt 45.99B 295M 257M 243M 221M 413M 28.27B 415M 2.9B 1.12B 14.37B 1.11B 1.08B -26.39B -169M -148M -140M -127M -237M -16.22B -238M -1.66B -643M -8.25B -636M -622M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
17/09/26 ¥2,291.50 +2.12% 3,177,500
16/09/26 ¥2,244.00 +0.07% 2,879,300
15/09/26 ¥2,242.50 -0.88% 2,588,100
14/09/26 ¥2,262.50 +0.73% 6,110,900
11/09/26 ¥2,246.00 +0.49% 6,580,400
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,291.50JPY
Average target price
3,110.00JPY
Spread / Average Target
+35.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!